DR info

Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20

Angelman syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
201	Angelman syndrome	-
6	Parkinson disease	22.000
2	Amyotrophic lateral sclerosis	22.000
17	Multiple system atrophy	22.000
140	Dorabe syndrome	22.000
8	Huntington disease	16.995
152	PCDH19 related syndrome	16.000
206	Fragile X syndrome	15.818
5	Progressive supranuclear palsy	15.634
97	Ulcerative colitis	15.139
13	Multiple sclerosis/Neuromyelitis optica	14.949
21	Mitochondrial disease	14.534
205	Fragile X syndrome related disease	14.429
272	Fibrodysplasia ossificans progressiva	14.322
145	West syndrome	14.222
75	Cushing disease	14.196
70	Spinal stenosis	14.132
22	Moyamoya disease	14.130
155	Acquired aphasia with convulsive disorder	14.044
156	Rett syndrome	13.989
231	Alpha-1-antitrypsin deficiency	13.631
158	Tuberous sclerosis	13.631
46	Malignant rheumatoid arthritis	13.491
98	Eosinophilic gastrointestinal disease	13.339
18	Spinocerebellar degeneration	13.188
296	Biliary atresia	13.188
36	Epidermolysis bullosa	13.061
144	Lennox-Gastaut syndrome	13.061
193	Prader-Willi syndrome	13.005
298	Hereditary pancreatitis	12.954
3	Spinal muscular atrophy	12.954
84	Sarcoidosis	12.488
34	Neurofibromatosis	12.439
96	Crohn disease	12.052
7	Corticobasal degeneration	3.283
4	Primary lateral sclerosis	3.014
164	Oculocutaneous albinism	2.406
309	Progressive myoclonus epilepsy	2.352
74	Prolactin secreting pituitary adenoma	2.344
90	Retinitis pigmentosa	2.171
299	Cystic fibrosis	1.338